Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation.

Wegener, Alma; Andersen, Niels Smedegaard; Friis, Lone Smidstrup; Petersen, Søren Lykke; Schjødt, Ida; Kornblit, Brian; Sengeløv, Henrik; Gjærde, Lars Klingen

Wegener, Alma; Andersen, Niels Smedegaard; Friis, Lone Smidstrup; Petersen, Søren Lykke; Schjødt, Ida; Kornblit, Brian; Sengeløv, Henrik; Gjærde, Lars Klingen.

Afiliación

Wegener A; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: alma.scheel.wegener.01@regionh.dk.
Andersen NS; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Friis LS; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Petersen SL; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Schjødt I; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kornblit B; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Sengeløv H; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Gjærde LK; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Transplant Cell Ther ; 29(9): 575.e1-575.e6, 2023 09.

Article en En | MEDLINE | ID: mdl-37301257

Asunto(s)

Enfermedad Injerto contra Huésped; Trasplante de Células Madre Hematopoyéticas; Adulto; Humanos; Masculino; Femenino; Persona de Mediana Edad; Anciano; Adolescente; Tacrolimus/uso terapéutico; Donante no Emparentado; Trasplante de Células Madre Hematopoyéticas/efectos adversos; Enfermedad Injerto contra Huésped/epidemiología; Enfermedad Injerto contra Huésped/prevención & control; Enfermedad Injerto contra Huésped/tratamiento farmacológico; Sirolimus; Ácido Micofenólico/uso terapéutico; Ciclosporina/uso terapéutico; Recurrencia

Palabras clave

Allogenic hematopoietic stem cell transplantation; Graft-versus-host disease; Graft-versus-host disease prophylaxis; Nonmyeloablative; Sirolimus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Transplant Cell Ther Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google